Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 EUR | +2.74% | +2.74% | -6.83% |
03-14 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
03-11 | Abionyx: reduced net loss in 2023 | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.83% | 40.76M | |
+10.52% | 115B | |
+12.26% | 106B | |
-5.43% | 24.69B | |
-1.60% | 21.97B | |
-5.38% | 19.27B | |
-11.42% | 17.56B | |
-39.36% | 17.32B | |
+5.75% | 14.03B | |
+33.36% | 12.13B |
- Stock Market
- Equities
- ABNX Stock
- News ABIONYX Pharma
- Cerenis Therapeutics Holding SA Provides Revenue Guidance for the First Half of 2019